Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Wu, Joseph C  [Clear All Filters]
Journal Article
Nguyen, P.K., Rhee, J.-W., and Wu, J.C. (2016). Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review.Jama Cardiol.
Vrtovec, B., Poglajen, G., Sever, M., Lezaic, L., Socan, A., Haddad, F., and Wu, J.C. (2013). CD34(+) Stem Cell Therapy in Non-Ischemic Dilated Cardiomyopathy Patients.Clin Pharmacol Ther.
Burridge, P.W., Matsa, E., Shukla, P., Lin, Z.C., Churko, J.M., Ebert, A.D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N.M., et al. (2014). Chemically defined generation of human cardiomyocytes.Nat Methods.
Chan, C.K.F., Lindau, P., Jiang, W., Chen, J.Y., Zhang, L.F., Chen, C.-C., Seita, J., Sahoo, D., Kim, J.-B., Lee, A., et al. (2013). Clonal precursor of bone, cartilage, and hematopoietic niche stromal cells.Proc Natl Acad Sci U S A.
Kernik, D.C., Morotti, S., Wu, H., Garg, P., Duff, H.J., Kurokawa, J., Jalife, J., Wu, J.C., Grandi, E., and Clancy, C.E. (2019). A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources.J Physiol.
Lam, C.Keung, and Wu, J.C. (2018). Disease modelling and drug discovery for hypertrophic cardiomyopathy using pluripotent stem cells: how far have we come?.Eur Heart J.
Poglajen, G., Sever, M., Cukjati, M., Cernelc, P., Knezevic, I., Zemljic, G., Haddad, F., Wu, J.C., and Vrtovec, B. (2014). Effects of Transendocardial CD34+ Cell Transplantation in Patients With Ischemic Cardiomyopathy.Circ Cardiovasc Interv.
He, N., Xu, Y., Du, W., Qi, X., Liang, L., Wang, Y., Feng, G., Fan, Y., Han, Z., Kong, D., et al. (2015). Extracellular Matrix can Recover the Downregulation of Adhesion Molecules after Cell Detachment and Enhance Endothelial Cell Engraftment.Sci Rep5, 10902.
Williams, I.M., and Wu, J.C. (2019). Generation of Endothelial Cells From Human Pluripotent Stem Cells.Arterioscler Thromb Vasc Biol39, 1317-1329.
Churko, J.M., Burridge, P.W., and Wu, J.C. (2013). Generation of Human iPSCs from Human Peripheral Blood Mononuclear Cells Using Non-integrative Sendai Virus in Chemically Defined Conditions.Methods Mol Biol1036, 81-88.
Garg, P., Oikonomopoulos, A., Chen, H., Li, Y., Lam, C.Keung, Sallam, K., Perez, M., Lux, R.L., Sanguinetti, M.C., and Wu, J.C. (2018). Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant.J Am Coll Cardiol72, 62-75.
Bhattacharya, S., Burridge, P.W., Kropp, E.M., Chuppa, S.L., Kwok, W.-M., Wu, J.C., Boheler, K.R., and Gundry, R.L. (2014). High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry.J Vis Exp.
Riegler, J., Tiburcy, M., Ebert, A., Tzatzalos, E., Raaz, U., Abilez, O.J., Shen, Q., Kooreman, N.G., Neofytou, E., Chen, V., et al. (2015). Human Engineered Heart Muscles Engraft and Survive Long-Term in a Rodent Myocardial Infarction Model.Circ Res.
Burridge, P.W., Li, Y.Fuga, Matsa, E., Wu, H., Ong, S.-G., Sharma, A., Holmström, A., Chang, A.C., Coronado, M.J., Ebert, A.D., et al. (2016). Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.Nat Med.
Chanana, A.M., Rhee, J.-W., and Wu, J.C. (2016). Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases.Curr Opin Cardiol.
Neofytou, E., O'Brien, C.Galen, Couture, L.A., and Wu, J.C. (2015). Hurdles to clinical translation of human induced pluripotent stem cells.J Clin Invest125, 2551-2557.
Haddad, F., Sever, M., Poglajen, G., Lezaic, L., Yang, P., Maecker, H., Davis, M., Kuznetsova, T., Wu, J.C., and Vrtovec, B. (2015). Immune Network and Response to Intramyocardial CD34+ Stem Cell Therapy in Patients with Dilated Cardiomyopathy.J Card Fail.
Zhao, H., Sun, N., Young, S.R., Nolley, R., Santos, J., Wu, J.C., and Peehl, D.M. (2013). Induced Pluripotency of Human Prostatic Epithelial Cells.Plos One8, e64503.
Wilson, K.D., and Wu, J.C. (2015). Induced Pluripotent Stem Cells.Jama313, 1613-1614.
Wang, L., Pegram, M.D., and Wu, J.C. (2019). Induced Pluripotent Stem Cells as a Novel Cancer Vaccine.Expert Opin Biol Ther.
Sa, S., Gu, M., Chappell, J., Shao, N.-Y., Ameen, M., Elliott, K.A.T., Li, D., Grubert, F., Li, C.G., Taylor, S., et al. (2016). iPSC Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity.Am J Respir Crit Care Med.
Wu, H., Yang, H., Rhee, J.-W., Zhang, J.Z., Lam, C.Keung, Sallam, K., C Y Chang, A., Ma, N., Lee, J., Zhang, H., et al. (2019). Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.Eur Heart J.
Smith, A., Choi, E., Gray, K., Macadangdang, J., Ahn, E.Hyun, Clark, E.C., Laflamme, M., Wu, J.C., Murry, C.E., Tung, L., et al. (2019). NanoMEA: a tool for high-throughput, electrophysiological phenotyping of patterned excitable cells.Nano Lett.
Nguyen, P.K., Neofytou, E., Rhee, J.-W., and Wu, J.C. (2016). Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review.Jama Cardiol.
Wnorowski, A., Yang, H., and Wu, J.C. (2018). Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models.Adv Drug Deliv Rev.

Pages